Insights

Innovative Dermatology Focus BioPharmX specializes in developing treatments for chronic dermatologic conditions, particularly rosacea and acne vulgaris, addressing unmet medical needs in dermatology with proprietary delivery systems. This indicates opportunities to partner or supply specialized dermatology products to clinics and healthcare providers seeking effective solutions.

Limited Market Penetration With recent revenues between one and ten million dollars and a modest team size, BioPharmX is an emerging player with growth potential. Sales efforts could focus on expanding distribution channels, dermatology clinics, and specialty pharmacies to accelerate market reach for their innovative products.

Strategic Leadership Expansion The appointment of experienced pharmaceutical executives as COO and CEO suggests a company poised for growth and strategic development. Engaging with the company to offer supportive technologies, distribution partnerships, or co-marketing initiatives may align with their expansion plans.

Technology-Driven Development Utilizing advanced digital tools like New Relic and Google Maps indicates a tech-savvy approach to product development and operations. Opportunities exist to introduce digital health solutions, patient engagement platforms, or data analytics services to complement their R&D efforts.

Funding and Growth Potential Having secured nearly eight million dollars in funding provides BioPharmX with resources for product development and market expansion. Business development efforts could focus on offering scalable manufacturing, distribution, or licensing solutions to support their growth trajectory in the dermatology sector.

BioPharmX Tech Stack

BioPharmX uses 8 technology products and services including WordPress, Google Fonts API, Twemoji, and more. Explore BioPharmX's tech stack below.

  • WordPress
    Content Management System
  • Google Fonts API
    Font Scripts
  • Twemoji
    Font Scripts
  • jQuery UI
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Google Maps
    Maps
  • New Relic
    Real User Monitoring
  • Adobe Fonts
    Web Fonts

BioPharmX's Email Address Formats

BioPharmX uses at least 1 format(s):
BioPharmX Email FormatsExamplePercentage
FLast@biopharmx.comJDoe@biopharmx.com
29%
Last@biopharmx.comDoe@biopharmx.com
21%
FLast@biopharmx.comJDoe@biopharmx.com
29%
Last@biopharmx.comDoe@biopharmx.com
21%

Frequently Asked Questions

What is BioPharmX's phone number?

Minus sign iconPlus sign icon
You can contact BioPharmX's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioPharmX's stock symbol?

Minus sign iconPlus sign icon
BioPharmX is a publicly traded company; the company's stock symbol is TMBRQ.

What is BioPharmX's official website and social media links?

Minus sign iconPlus sign icon
BioPharmX's official website is biopharmx.com and has social profiles on LinkedInCrunchbase.

What is BioPharmX's SIC code NAICS code?

Minus sign iconPlus sign icon
BioPharmX's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioPharmX have currently?

Minus sign iconPlus sign icon
As of December 2025, BioPharmX has approximately 11 employees across 2 continents, including North AmericaAsia. Key team members include Co-Founder And Executive Vp R&d/Technology: K. C.Executive Vice President And Chief Financial Officer: G. K.Senior Vice President Corporate Development: M. B.. Explore BioPharmX's employee directory with LeadIQ.

What industry does BioPharmX belong to?

Minus sign iconPlus sign icon
BioPharmX operates in the Biotechnology Research industry.

What technology does BioPharmX use?

Minus sign iconPlus sign icon
BioPharmX's tech stack includes WordPressGoogle Fonts APITwemojijQuery UIModernizrGoogle MapsNew RelicAdobe Fonts.

What is BioPharmX's email format?

Minus sign iconPlus sign icon
BioPharmX's email format typically follows the pattern of FLast@biopharmx.com. Find more BioPharmX email formats with LeadIQ.

How much funding has BioPharmX raised to date?

Minus sign iconPlus sign icon
As of December 2025, BioPharmX has raised $7.9M in funding. The last funding round occurred on Mar 18, 2015 for $7.9M.

When was BioPharmX founded?

Minus sign iconPlus sign icon
BioPharmX was founded in 2011.

BioPharmX

Biotechnology ResearchCalifornia, United States11-50 Employees

BioPharmX Corporation (NYSE American: BPMX) is a specialty pharmaceutical company focused on developing products that treat chronic dermatologic conditions that are not being adequately addressed or those where current therapies and approaches are suboptimal. The Company is developing prescription products through its proprietary HyantX™ delivery system for dermatology indications. BioPharmX has two lead products in development, BPX-04 for the treatment of papulopustular rosacea and BPX-01 for the treatment of acne vulgaris.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TMBRQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $7.9M

    BioPharmX has raised a total of $7.9M of funding over 3 rounds. Their latest funding round was raised on Mar 18, 2015 in the amount of $7.9M.

  • $1M$10M

    BioPharmX's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $7.9M

    BioPharmX has raised a total of $7.9M of funding over 3 rounds. Their latest funding round was raised on Mar 18, 2015 in the amount of $7.9M.

  • $1M$10M

    BioPharmX's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.